Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. 1993

M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN 38105.

The contribution of infused bone marrow cells to long-term haemopoietic recovery in patients undergoing autologous bone marrow transplantation is unknown. Such information would help to clarify the role of this procedure in cancer therapy and would aid in the development of strategies to reduce the risk of subsequent aplasia. By transferring a neomycin resistance marker gene into the marrow cells of 20 patients before transplantation, we were able to trace the pattern of haemopoietic reconstitution postinfusion. The marker gene was present and expressed in all haemopoietic lineages in vivo in 15 of 18 evaluable patients at 1 month post-transplantation, in 8 of 9 patients at 6 months, and in 5 of 5 at 1 year. The marker has remained detectable for up to 18 months--the duration of our study. Our findings indicate that harvested bone marrow consistently contributes to long-term multilineage recovery of haemopoiesis after autologous marrow transplantation in cancer patients. These results provide a rationale for the continued exploration of more ablative preparative regimens with single or sequential autologous marrow transplants.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
November 1994, British journal of haematology,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
January 1979, Acta haematologica,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
March 1997, Veterinary immunology and immunopathology,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
June 2017, Cell transplantation,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
July 2012, British journal of cancer,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
January 1986, Leukemia research,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
October 2013, Cell death & disease,
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
September 1989, Cancer cells (Cold Spring Harbor, N.Y. : 1989),
M K Brenner, and D R Rill, and M S Holladay, and H E Heslop, and R C Moen, and M Buschle, and R A Krance, and V M Santana, and W F Anderson, and J N Ihle
August 1999, Human gene therapy,
Copied contents to your clipboard!